Linsitinib Impurities | Pharmaffiliates

Linsitinib

Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor. This prevents tumor cell proliferation and induces tumor cell apoptosis. Reference standards of Linsitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Linsitinib - API Standards 
    [catalogue_number] => PA 65 29000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 421.5
    [form] => C26H23N5O
    [cas] => 867160-71-2
    [pslug] => 867160-71-2-linsitinib-api-pa6529000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 65 29000

Linsitinib - API Standards


  • Catalogue No.:PA 65 29000

  • CAS :

    867160-71-2

  • Molecular Formula : C26H23N5O

  • Molecular Weight : 421.5